US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs in Tipperary following its acquisition of the former Johnson & Johnson plant in Cashel.
The 200,000 square foot facility was sold to Amneal by Singapore-based investment firm Solidus Private Equity. The former Johnson & Johnson plant had been vacant for four years before being acqured by Solidus earlier this year.
Amneal said the Cashel site will be dedicated to R&D and production of metered dose and dry powder inhalers as well as biosimilars .
Amneal co-chief executive Chintu Patel said the company expects to hire an estimated 250-300 employees at full build-out. From its start in 2002 as a contract drug manufacturer, Amneal has grown dramatically to its current position as the 7th largest US generics supplier by volume.
“Our new Ireland facility is critical to Amneal’s long-term global growth, in Europe, the US and throughout the world,” Chintu Patel, Amneal co-CEO and co-chairman
“This announcement is great news for Tipperary and the whole of the South East region. That Amneal has chosen to locate in a facility that had been occupied previously is especially pleasing”
Martin Shanahan, Chief Executive, IDA Ireland
Mike Morrissey has extensive knowledge of production, quality and engineering, having worked for Dell, Creative Labs and Tyco Safety Products /Sensormatic.
His expansive operational experience is grounded with training as a Six Sigma Black Belt.
As a lead auditor, he is very familiar with compliance and quality standards and has project managed the implementation of the environmental standard ISO14001. He has successfully utilised his project management and team leading skills in implementing numerous cost-saving and process improvement projects.
Since joining CareerWise Recruitment, Mike has graduated with a Diploma in Personnel Management from UCC and is a Chartered member of the CIPD.
Upload your CV to apply for as many jobs as you like.upload your CV